Penumbra's average Accounts Receivable for the
three
months ended in Dec. 2023 was $204 Mil. Penumbra's Revenue for the
three
months ended in Dec. 2023 was $285 Mil.
Hence, Penumbra's Days Sales Outstanding for the
three
months ended in Dec. 2023 was 65.45.
The historical rank and industry rank for Penumbra's Days Sales Outstanding or its related term are showing as below:
PEN'
s Days Sales Outstanding Range Over the Past 10 Years
Min: 46.51 Med: 59.03 Max: 72.67
Current: 70.9
During the past 12 years, Penumbra's highest Days Sales Outstanding was 72.67. The lowest was 46.51. And the median was 59.03.
PEN's Days Sales Outstanding is ranked worse than 58.12% of 807
companies
in the Medical Devices & Instruments industry
Industry Median: 63.94
vs PEN: 70.90
Penumbra's Days Sales Outstanding
declined
from Dec. 2022 (80.93) to Dec. 2023 (65.45).
Penumbra Days Sales Outstanding Historical Data
The historical data trend for Penumbra's Days Sales Outstanding can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Penumbra's Days Sales Outstanding
For the Medical Devices subindustry, Penumbra's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Penumbra's Days Sales Outstanding Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Penumbra's Days Sales Outstanding distribution charts can be found below:
* The bar in red indicates where Penumbra's Days Sales Outstanding falls into.
Penumbra Days Sales Outstanding Calculation
Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Penumbra (NYSE:PEN) Days Sales Outstanding Explanation
For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.
Penumbra Days Sales Outstanding Related Terms
Thank you for viewing the detailed overview of Penumbra's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.
Penumbra Inc develops and manufactures medical devices for the neurovascular and peripheral vascular markets. Its products are primarily sold to hospitals and are developed for use by specialist physicians. The neurovascular product category contributes to the majority of revenue. Within the neurovascular business, the firm offers products for neurovascular access, ischemic stroke, neurovascular embolization, and neurosurgical tool markets. In the peripheral vascular business, the firm sells devices related to peripheral embolization and peripheral thrombectomy. Penumbra generates the majority of its revenue in the United States.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
PEN has been successfully added to your 